CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-03 | Jacobson Mark L. Chief Operating Officer | Option exercise 10b5-1 | +10,000 | $12.95 | $130K | 10,000 |
| 2026-09-03 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −10,000 | $208.65 | $2.1M | 0 |
| 2026-09-03 | Jacobson Mark L. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 104,954 | ||
| 2026-08-06 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise 10b5-1 | +4,660 | $4.95 | $23K | 11,889 |
| 2026-08-06 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −4,660 | $213.95 | $997K | 7,229 |
| 2026-08-06 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,660 | 0 | ||
| 2026-08-05 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise 10b5-1 | +45,004 | $4.95 | $223K | 52,233 |
| 2026-08-05 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −45,004 | $212.01 | $9.5M | 7,229 |
| 2026-08-05 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −45,004 | 4,660 | ||
| 2026-07-01 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise 10b5-1 | +49,666 | $4.95 | $246K | 56,895 |
| 2026-07-01 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −49,666 | $240.25 | $11.9M | 7,229 |
| 2026-07-01 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −49,666 | 49,664 | ||
| 2026-06-11 | JEFFS ROGER Director | Sale 10b5-1 | −286 | $249.12 | $71K | 58,367 |
| 2026-06-10 | JEFFS ROGER Director | Sale 10b5-1 | −286 | $246.18 | $70K | 58,653 |
| 2026-06-10 | Mahony Susan Director | Sale 10b5-1 | −300 | $246.18 | $74K | 829 |
| 2026-06-10 | Coleman Mark Director | Sale 10b5-1 | −643 | $249.00 | $160K | 30,389 |
| 2026-06-09 | Mahony Susan Director | Sale 10b5-1 | −300 | $237.21 | $71K | 1,129 |
| 2026-06-09 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise 10b5-1 | +49,670 | $4.95 | $246K | 56,899 |
| 2026-06-09 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −49,670 | $241.01 | $12.0M | 7,229 |
| 2026-06-09 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −49,670 | 99,330 |
Page 1 of 22 · 422 trades